These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33650093)

  • 1. Bioinformatics Analysis Identifies IL6ST as a Potential Tumor Suppressor Gene for Triple-Negative Breast Cancer.
    Jia R; Weng Y; Li Z; Liang W; Ji Y; Liang Y; Ning P
    Reprod Sci; 2021 Aug; 28(8):2331-2341. PubMed ID: 33650093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
    Zhai Q; Li H; Sun L; Yuan Y; Wang X
    Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
    Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
    Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel biomarkers identified in triple-negative breast cancer through RNA-sequencing.
    Chen YL; Wang K; Xie F; Zhuo ZL; Liu C; Yang Y; Wang S; Zhao XT
    Clin Chim Acta; 2022 Jun; 531():302-308. PubMed ID: 35504321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Key Prognostic Genes of Triple Negative Breast Cancer by LASSO-Based Machine Learning and Bioinformatics Analysis.
    Chen DL; Cai JH; Wang CCN
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers.
    Liu Y; Teng L; Fu S; Wang G; Li Z; Ding C; Wang H; Bi L
    BMC Cancer; 2021 May; 21(1):644. PubMed ID: 34053447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of CCNE1 confers a poorer prognosis in triple-negative breast cancer identified by bioinformatic analysis.
    Yuan Q; Zheng L; Liao Y; Wu G
    World J Surg Oncol; 2021 Mar; 19(1):86. PubMed ID: 33757543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulated cyclins may be novel genes for triple-negative breast cancer based on bioinformatic analysis.
    Lu Y; Yang G; Xiao Y; Zhang T; Su F; Chang R; Ling X; Bai Y
    Breast Cancer; 2020 Sep; 27(5):903-911. PubMed ID: 32338339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated network analysis and machine learning approach for the identification of key genes of triple-negative breast cancer.
    Naorem LD; Muthaiyan M; Venkatesan A
    J Cell Biochem; 2019 Apr; 120(4):6154-6167. PubMed ID: 30302816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel key genes in triple-negative breast cancer identified by weighted gene co-expression network analysis.
    Chen J; Qian X; He Y; Han X; Pan Y
    J Cell Biochem; 2019 Oct; 120(10):16900-16912. PubMed ID: 31081967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of key genes as potential biomarkers for triple‑negative breast cancer using integrating genomics analysis.
    Zhong G; Lou W; Shen Q; Yu K; Zheng Y
    Mol Med Rep; 2020 Feb; 21(2):557-566. PubMed ID: 31974598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype.
    Chen Z; Wang M; De Wilde RL; Feng R; Su M; Torres-de la Roche LA; Shi W
    Front Immunol; 2021; 12():749459. PubMed ID: 34603338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of new subtypes and potential genetic signatures in triple-negative breast cancer using weighted gene co-expression network analysis.
    Huang J; Liao LY; Jiang WJ; Li YH; Lu BM; Wen ZP; Li FJ; Fang DL; Lu GM
    Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):603-614. PubMed ID: 38305604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Key Genes and Pathways in Triple-Negative Breast Cancer by Integrated Bioinformatics Analysis.
    Dong P; Yu B; Pan L; Tian X; Liu F
    Biomed Res Int; 2018; 2018():2760918. PubMed ID: 30175120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Landscape of toll-like receptors expression in tumor microenvironment of triple negative breast cancer (TNBC): Distinct roles of TLR4 and TLR8.
    Roychowdhury A; Jondhale M; Saldanha E; Ghosh D; Kumar Panda C; Chandrani P; Mukherjee N
    Gene; 2021 Aug; 792():145728. PubMed ID: 34022297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
    Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
    Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of FOXC1/FOXCUT/DANCR axis in triple negative breast cancer: a bioinformatics and experimental approach.
    Kamaliyan Z; Mirfakhraie R; Azizi-Tabesh G; Darbeheshti F; Omranipour R; Ahmadinejad N; Zokaei E; Yassaee VR
    Mol Biol Rep; 2022 Apr; 49(4):2821-2829. PubMed ID: 35066769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Group of Therapeutic Targets and Prognostic Biomarker for Triple Negative Breast Cancer.
    Li Y; Yang S; Qi L; Li Y; Wang X
    Adv Ther; 2024 Apr; 41(4):1621-1636. PubMed ID: 38421558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABCC9, NKAPL, and TMEM132C are potential diagnostic and prognostic markers in triple-negative breast cancer.
    Zhang X; Kang X; Jin L; Bai J; Zhang H; Liu W; Wang Z
    Cell Biol Int; 2020 Oct; 44(10):2002-2010. PubMed ID: 32544280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selected ideal natural ligand against TNBC by inhibiting CDC20, using bioinformatics and molecular biology.
    Liu N; Wang X; Zhu Z; Li D; Lv X; Chen Y; Xie H; Guo Z; Song D
    Aging (Albany NY); 2021 Oct; 13(20):23702-23725. PubMed ID: 34686627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.